← SynDRA
ML324
SynDRA canonical compound SYN0046931 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | KDM4A | KDM4E |
|---|
| Mechanism of action | histone lysine demethylase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- KDM4A INHIBITOR
- KDM4E INHIBITOR
Cross-references
Synonyms
- RefChem:159248
- ML 324
- Ml234
- MFCD28053518
- MLS002391556
- SMR001355524
- NCGC00183808-01
- MLS004685729
- GTPL9584
- orb1300631
- SCHEMBL14937894
- SCHEMBL29353478
- BDBM79334
- EX-A554
- cid_44143208
- GLXC-03280
- XYB80079
- NCGC00183808
- s7296
- AKOS027323940
- CCG-268027
- CS-3993
- ML-324?
- MMV1580488
- NCGC00183808-02
- NCGC00183808-03
- NCGC00183808-06
- NCGC00183808-12
- NCGC00183808-13
- NCGC00183808-17
- NCGC00183808-18
- AC-32787
- AS-72027
- DA-47097
- HY-12725
- ML324, >=98% (HPLC)
- SMR003457050
- T6593
- F861809
Look up ML324 in the interactive SynDRA portal →